Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

Rituximab monotherapy has proven efficacy in treatment-naïve, asymptomatic advanced-stage follicular lymphoma (FL). Ofatumumab is a fully humanized anti-CD20 monoclonal antibody with increased CD20 affinity and complement-dependent cytotoxicity. This phase 2 trial (NCT01190449) evaluated ofatumumab...

全面介紹

Na minha lista:
書目詳細資料
發表在:Br J Haematol
Main Authors: Rosenbaum, Cara A., Jung, Sin-Ho, Pitcher, Brandelyn, Bartlett, Nancy L., Smith, Sonali M., Hsi, Eric, Wagner-Johnston, Nina, Thomas, Sachdev P., Leonard, John P., Cheson, Bruce D.
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6462222/
https://ncbi.nlm.nih.gov/pubmed/30723894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15768
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍